2B70.DE vs. QDVG.DE
Compare and contrast key facts about iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and iShares S&P 500 Health Care Sector UCITS ETF (Acc) (QDVG.DE).
2B70.DE and QDVG.DE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. 2B70.DE is a passively managed fund by iShares that tracks the performance of the Nasdaq Biotechnology. It was launched on Oct 19, 2017. QDVG.DE is a passively managed fund by iShares that tracks the performance of the S&P 500 Capped 35/20 Health Care. It was launched on Nov 20, 2015. Both 2B70.DE and QDVG.DE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: 2B70.DE or QDVG.DE.
Key characteristics
2B70.DE | QDVG.DE | |
---|---|---|
YTD Return | 14.75% | 14.68% |
1Y Return | 31.27% | 20.30% |
3Y Return (Ann) | 2.58% | 8.09% |
5Y Return (Ann) | 8.13% | 11.72% |
Sharpe Ratio | 1.87 | 1.89 |
Sortino Ratio | 2.76 | 2.75 |
Omega Ratio | 1.33 | 1.35 |
Calmar Ratio | 1.23 | 1.78 |
Martin Ratio | 8.57 | 9.13 |
Ulcer Index | 3.59% | 2.19% |
Daily Std Dev | 16.66% | 10.63% |
Max Drawdown | -30.87% | -26.77% |
Current Drawdown | -0.23% | -1.52% |
Correlation
The correlation between 2B70.DE and QDVG.DE is 0.71, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
2B70.DE vs. QDVG.DE - Performance Comparison
The year-to-date returns for both stocks are quite close, with 2B70.DE having a 14.75% return and QDVG.DE slightly lower at 14.68%. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
2B70.DE vs. QDVG.DE - Expense Ratio Comparison
2B70.DE has a 0.35% expense ratio, which is higher than QDVG.DE's 0.15% expense ratio.
Risk-Adjusted Performance
2B70.DE vs. QDVG.DE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and iShares S&P 500 Health Care Sector UCITS ETF (Acc) (QDVG.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
2B70.DE vs. QDVG.DE - Dividend Comparison
Neither 2B70.DE nor QDVG.DE has paid dividends to shareholders.
Drawdowns
2B70.DE vs. QDVG.DE - Drawdown Comparison
The maximum 2B70.DE drawdown since its inception was -30.87%, which is greater than QDVG.DE's maximum drawdown of -26.77%. Use the drawdown chart below to compare losses from any high point for 2B70.DE and QDVG.DE. For additional features, visit the drawdowns tool.
Volatility
2B70.DE vs. QDVG.DE - Volatility Comparison
iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) has a higher volatility of 3.90% compared to iShares S&P 500 Health Care Sector UCITS ETF (Acc) (QDVG.DE) at 2.76%. This indicates that 2B70.DE's price experiences larger fluctuations and is considered to be riskier than QDVG.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.